This marks Enhertu's sixth approved indication in the country, Daiichi noted. Back in 2020, the China Center for Drug Evaluation designated Enhertu a "breakthrough therapy" for the second-line gastric ...
Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback